T. Rowe Price Associates
CLS icon

T. Rowe Price Associates’s Celestica CLS Stock Holding History

T. Rowe Price Associates’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449M Sell
1,231,492
-68,404
-5% -$25.7M 0.05% 300
2026
Q1 		$366M Buy
1,299,896
+612,547
+89% +$178M 0.04% 320
2025
Q4 		$203M Buy
687,349
+305,265
+80% +$92M 0.02% 460
2025
Q3 		$94.1M Buy
382,084
+86,426
+29% +$17.4M 0.01% 635
2025
Q2 		$46.2M Buy
295,658
+91,802
+45% +$9.76M 0.01% 750
2025
Q1 		$16.1M Sell
203,856
-65,522
-24% -$6.95M ﹤0.01% 1001
2024
Q4 		$24.9M Buy
269,378
+106,931
+66% +$8.36M ﹤0.01% 944
2024
Q3 		$8.3M Sell
162,447
-4,025,022
-96% -$208M ﹤0.01% 1174
2024
Q2 		$240M Sell
4,187,469
-4,516,273
-52% -$228M 0.03% 387
2024
Q1 		$391M Buy
8,703,742
+8,368,293
+2,495% +$318M 0.05% 314
2023
Q4 		$9.82M Buy
+335,449
New +$8.92M ﹤0.01% 1099

Other funds holding CLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

T. Rowe Price Associates's CLS Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Celestica (CLS) stake by 5.3% in Q2 2026, selling an estimated $25.7M and leaving 1,231,492 shares worth $449M. The position accounts for 0.05% of the portfolio, ranked #300.

T. Rowe Price Associates first reported a position in CLS in Q4 2023 and has held it in 11 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • T. Rowe Price Associates held 1,231,492 shares of Celestica worth $449M as of Q2 2026.
  • T. Rowe Price Associates sold 68,404 Celestica shares in Q2 2026, an estimated $25.7M.
  • Celestica made up 0.05% of T. Rowe Price Associates's portfolio in Q2 2026, its #300 holding.
  • T. Rowe Price Associates first reported a position in Celestica in Q4 2023 and has held it in 11 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.